Johnson & Johnson (JNJ) earnings Q3 2026 – USFTB
Johnson & Johnson reported a slightly higher-than-expected profit on Tuesday, driven by strong sales of immune disease treatment Tremfya, but geopolitical issues, including the Middle East conflict, were a drag on its medical devices business.…
Read More